A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2019
Price : $35 *
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors ADVANZ PHARMA; Concordia International Corp.
- 25 Mar 2019 Planned End Date changed from 1 Apr 2019 to 22 Mar 2019.
- 25 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 22 Mar 2019.
- 25 Mar 2019 Status changed from active, no longer recruiting to completed.